News

Stay Up-To-Date on NEXT Oncology

  • All
  • NEXT Oncology Blog
  • NEXT Oncology News
  • Press Releases

NEXT Oncology and MediLink Team Up on Phase 1 Clinical Trial

FOR IMMEDIATE RELEASE  DATE: October 9, 2023 Contact:  Lisa Owens, 210-601-6647 NEXT Oncology and MediLink Therapeutics Take “Team Approach” to Next Level on Phase 1 First in Human Clinical Trial …

Solid Tumors: First-in-human trial of CBX-12 an Alphalex PDC

Ismael Rodriguez Rivera, MD, Medical Oncologist and Clinical Investigator from NEXT Oncology, has conducted a groundbreaking study on a novel therapeutic approach for patients with advanced or metastatic solid tumors. Read …

ZielBio to Present Interim Findings from its Phase 1/2

ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases, will present the first set of clinical data from its lead asset, ZB131, directed …

Machine Learning in the Diagnosis of Gastric Cancer and Pulmonary Nodule Workup

Machine learning algorithms are increasingly being applied across different areas of medicine and oncology to analyze large data sets and draw conclusions that may otherwise escape the human eye. Indeed, …

Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service …

NEXT Oncology is the perfect place to compassionately improve outcomes for patients with cancer, now and in the future.

“Cancer has no geographic boundaries,” said Dr. Tolcher, CEO and founder of NEXT Oncology. “One of the continuing challenges has been that cancer research has been conducted in silos. Our goal …

Drug Development in Gastric Cancer: Are We at an Inflection Point?

Gastric cancer drug development has long been thwarted by the challenges of identifying effective targets and developing drugs against the backdrop of the cancer’s inherent tumor heterogeneity.1 Recently, however, advances in …

Update on Conservative Management of the Axilla when the Sentinel Node is Positive in Breast cancer.

Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. …

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor

SAN DIEGO and SHANGHAI, May 5, 2023 /PRNewswire/ — ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, …

Video: Expanded Phase 1 Program to the Dallas Area

In this video hosted by Oncology Tube, Anthony Tolcher, MD, discusses Cancer Drug Research: Expanded Phase 1 Program to the Dallas Area. iFrame is not supported!